Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the explicit monetary value per quality-adjusted life was in the context of Interventions and Regulations, as quoted as part of his Department's submission to the Inter-Departmental Group for the Valuation of Life and Health review in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will place in the Library a copy of the National Institute for Health and Care Excellence's submission to the Inter-Departmental Group for the Valuation of Life and Health review and all evidence submitted to the series of interviews with his Department's staff conducted by researchers from the University of Leeds in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what monetary thresholds were applied to the cost-per-quality adjusted life year quoted in the evidence submitted as part of the Food Standards Agency's work with the Inter-departmental Group for the Valuation of Life and Health review in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what monetary thresholds were applied to the cost-per-quality adjusted life year quoted in the evidence submitted as part of the Health Protection Agency's work with the Inter-departmental Group for the Valuation of Life and Health review in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what the explicit monetary value per quality-adjusted life was in the context of Advice on Nuclear power, centre for infections and modelling, as quoted as part of his Department's submission to the Inter-Departmental Group from the Valuation of Life and Health review in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, if he will place in the Library a copy of his Department's submission to the Inter-Departmental Group for the Valuation of Life and Health review and all evidence submitted to the series of interviews with his Department's staff conducted by researchers from the University of Leeds in 2008.
Answered by Dan Poulter
I refer my Rt. hon. Friend to the answer given on 26 June 2014, Official Report, column 283W.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer of 6 May 2014, Official Report, column 129W, on haemolytic uraemic syndrome, if he will place in the Library copies of the communications with (a) the Advisory Group for National Specialised Services of 17 January 2013 and (b) the National Institute for Care Excellence of 7 February 2013; and if he will make a statement.
Answered by Norman Lamb
The information requested has been placed in the Library.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer of 6 May 2014, Official Report, column 152W, on prescriptions, what the most plausible cost per quality adjusted life-year was for each technology appraisal conducted by the National Institute for Health and Care Excellence in the last two years; what the estimated eligible patient population was for each appraised indication; on which appraisals end-of-life criteria were applied in each final determination; and on what date each such appraisal was (a) initiated and (b) concluded.
Answered by Jane Ellison
The information requested has been placed in the Library.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, with reference to the Answer of 6 May 2014, Official Report, column 152W, on prescriptions, above what period of time the costs of providing the information requested become disproportionate.
Answered by Norman Lamb
Based on calculations by the National Institute for Health and Care Excellence, the information requested by my hon. Friend could only be provided for the four years from June 2010 without incurring disproportionate cost.
Asked by: Stephen O'Brien (Conservative - Eddisbury)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health, what assessment (a) his Department and (b) the National Institute for Health and Care Excellence (NICE) have made of the effectiveness of NICE's approach to appraising highly specialised technologies.
Answered by Norman Lamb
We have made no such assessment.
The first topic to be evaluated through the National Institute for Health and Care Excellence's (NICE) highly specialised technologies programme, eculizumab for atypical haemolytic uraemic syndrome, is currently in progress. NICE has advised that it has not yet reviewed its process for evaluating such technologies.